MET and neoplasm: A limitation is that we did not directly assess HHLA2’s impact on immune cell c-Met; therefore, further investigation is needed to fully elucidate the interplay between HHLA2, c-Met signaling on both tumor and immune cells, and the overall immune microenvironment.